Goldman Sachs Group Inc Trans Medics Group, Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 539,854 shares of TMDX stock, worth $41.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

539,854

Previous 293,411 83.99%

Holding current value

$41.7 Million

Previous $44.2 Million 91.79%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$135.68 - $176.11 $33.4 Million - $43.4 Million	246,443 Added 83.99%	539,854 $84.8 Million
Q2 2024 Aug 13, 2024	BUY	$72.62 - $150.62 $605,505 - $1.26 Million	8,338 Added 2.92%	293,411 $44.2 Million
Q1 2024 May 15, 2024	SELL	$70.86 - $89.93 $7.95 Million - $10.1 Million	-112,210 Reduced 28.24%	285,073 $21.1 Million
Q4 2023 Feb 13, 2024	BUY	$36.74 - $81.08 $1.43 Million - $3.16 Million	38,951 Added 10.87%	397,283 $31.4 Million
Q3 2023 May 14, 2024	SELL	$53.47 - $96.07 $2.08 Million - $3.74 Million	-38,951 Reduced 9.8%	358,332 $19.6 Million
Q3 2023 Nov 14, 2023	BUY	$53.47 - $96.07 $2.17 Million - $3.89 Million	40,498 Added 12.74%	358,332 $19.6 Million
Q2 2023 May 14, 2024	BUY	$66.23 - $88.73 $14.5 Million - $19.5 Million	219,615 Added 223.6%	317,834 $26.7 Million
Q2 2023 Aug 14, 2023	BUY	$66.23 - $88.73 $14.5 Million - $19.5 Million	219,615 Added 223.6%	317,834 $26.7 Million
Q1 2023 May 14, 2024	SELL	$53.63 - $82.33 $1.28 Million - $1.97 Million	-23,957 Reduced 19.61%	98,219 $7.44 Million
Q1 2023 May 11, 2023	SELL	$53.63 - $82.33 $1.28 Million - $1.97 Million	-23,957 Reduced 19.61%	98,219 $7.44 Million
Q4 2022 May 14, 2024	SELL	$39.08 - $64.29 $1.98 Million - $3.26 Million	-50,732 Reduced 29.34%	122,176 $7.54 Million
Q4 2022 Feb 13, 2023	SELL	$39.08 - $64.29 $1.98 Million - $3.26 Million	-50,732 Reduced 29.34%	122,176 $7.54 Million
Q3 2022 May 14, 2024	BUY	$31.56 - $55.75 $4.24 Million - $7.5 Million	134,442 Added 349.51%	172,908 $7.22 Million
Q3 2022 Nov 10, 2022	BUY	$31.56 - $55.75 $4.24 Million - $7.5 Million	134,442 Added 349.51%	172,908 $7.22 Million
Q2 2022 May 14, 2024	SELL	$20.56 - $32.15 $7.38 Million - $11.5 Million	-358,817 Reduced 90.32%	38,466 $1.21 Million
Q2 2022 Aug 15, 2022	BUY	$20.56 - $32.15 $252,620 - $395,027	12,287 Added 46.93%	38,466 $1.21 Million
Q1 2022 May 16, 2022	BUY	$12.58 - $26.94 $135,109 - $289,335	10,740 Added 69.56%	26,179 $705,000
Q4 2021 Feb 14, 2022	SELL	$19.16 - $32.68 $101,126 - $172,485	-5,278 Reduced 25.48%	15,439 $296,000
Q3 2021 Nov 10, 2021	BUY	$25.92 - $34.51 $536,984 - $714,943	20,717 New	20,717 $686,000

Others Institutions Holding TMDX

# of Institutions

396

Shares Held

31.9M

Call Options Held

466K

Put Options Held

286K

View Full List

About TransMedics Group, Inc.

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.46B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

More about TMDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Trans Medics Group, Inc. Transaction History